Replies to post #17790 on Amarin Corp Plc (AMRN)

[Biobillionair]

Chab, the AACE recommends "AGRESSIVE" treat for those DM 2 patients that have had an event to a Trig level of under 150! Not 200! Read the document in full. They caution against DHA that could raise LDL!

I fed this to you people weeks ago! Run, spread the news! 150 is the guideline not 200!

The FDA can ONLY break SPA agreement for SAFETY (Not presented by the FDA!) or change in clinical efficacy ??...!

They have neither!

FDA Coleman gave his safety blessing statement.

AACE gave guideline.

Both are written documents admissible in a court of law.

The FDA gave Amarin no indication of wanting to break SPA, this means they don't intend to break SPA. They have to follow guidance, those that sold got screwed....including the dumb HF that should pay me millions to consults for them. December 20 th. Amarin needs to negotiate label...I suggest they recommend whatever the AACE feels comfortable with.

150!!!!! Not 200!!!!

[Ajax133]

CHAB: You are absolutely right. I believe most on this
site are also in agreement. Unfortunately the FDA can
damm well do whatever they want. They are accountable
only to The Dept of Health and Human Services, and
I don't see them stepping in. I've agonized about
yesterdays vote and came to the following conclusions.

1- I estimate the PDUFA approval a tad higher than most
about 25%. Nothing can be done for 2 months.

2-AMRN's future IMO can also be influenced by a hostile
takeover. GSK would be my first choice.

3- Some smart Wall Street types may like the long term
fundamentals and Private Equity may tender to take the
company Private. Vascepa is a very valuable asset.
GOING PRIVATE may allow the Co breathing room without
time lines or pressure from the shorts.

4-A management change would be extremely positive.

Hopefully we're not dead right.